Comparison of the cerebral function before and after the oxytocin administration for patients with autism spectrum disorder: open study using positron emission tomography and magnetoencephalography.

Comparison of the cerebral function before and after the oxytocin administration for patients with autism spectrum disorder: open study using positron emission tomography and magnetoencephalography. - Comparison of the cerebral function before and after the oxytocin administration for patients with autism spectrum disorder.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011077

Enrollment

Registered

2013-08-20

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder (high functioning)

Interventions

Oxytocin nasal administration

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: - The patient diagnosed as the autism spectrum obstacle - Male patient - A patient aged 20 and over [ time of consent acquisition ] - The patient whose intelligence quotient is 85 or more

Exclusion criteria

Exclusion criteria: - The patient who has hypersensitivity in oxytocin - A patient with the past history of the head injury accompanied by the consciousness disorder for 5 minutes or more - Patient with the history of substance-dependence. -The patient who consumes water more than 3 liters a day.

Design outcomes

Primary

Measure	Time frame
Change of the serotonin transporter density after the drug treatment (ten weeks).	—

Secondary

Measure	Time frame
Brain response to social stimuli recorded by MEG.	—

Countries

Japan

Contacts

Public ContactKikuchi Mitsuru

Kanazawa University Department of Psychiatry and Neurobiology

mitsuruk@med.kanazawa-u.ac.jp0762652307

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026